ClinicalTrials.gg
Drug

Rifabutin clinical trials

Also written Mycobutin.

studies test it
46
open now
3
in phase 3
9
first study started
1994

How each study uses Rifabutin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Rifabutin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Dec 1992 · MYCOBUTIN · NDA 050689 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rifabutin
37
Rifabutin 150 MG
2

Development codes

Mycobutin
7

Studies by the year they started

34 studies that test it; most in 1999 (3)

Studies that test Rifabutin, by start year
YearStudies
19941
19951
19981
19993
20001
20031
20082
20092
20102
20112
20121
20132
20141
20151
20171
20182
20191
20203
20212
20221
20232
20261

By phase

A phase 1/2 study counts in both.

Phase 1
13
Phase 2
10
Phase 3
9
Phase 4
9
No phase
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 31

Pharmacia (6) · Centers for Disease Control and Prevention (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · The University of Texas Health Science Center at Tyler (3) · ViiV Healthcare (2) · Boehringer Ingelheim (2) · Shanghai Jiao Tong University School of Medicine (1) · BeiGene (1)

Often tested with

Tested in the same studies.

Clarithromycin (4) · Ritonavir (4) · Bedaquiline (3) · Azithromycin (3) · Moxifloxacin (2) · Lopinavir-ritonavir drug combination (2) · Nevirapine (2) · Efavirenz (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 2 in phase 3

Studies that test Rifabutin, phase 3 first.

Studies

Open first, then newest update. How each study uses Rifabutin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 46

See all 46 studies that test Rifabutin →

Given beside what is tested · 9 — Rifabutin is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Rifabutin

Codes

What other systems call Rifabutin · ClinicalTrials.gg INT008615

  • MeSH (NLM) D017828RifabutinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 1W306TDA6SRIFABUTINConfirmed FDA, NLM, Wikidata
  • RxNorm 55672Confirmed FDA, Wikidata
  • Wikidata Q1135705rifabutinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1408RifabutinOne source FDA
  • DrugBank DB00615One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.